Skip to main content

STIFEL FINANCIAL CORP

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 720672 ST. LOUIS, MO

Position in ALNY

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$16,528,277
+$8,405,484 QoQ
Shares Held
49,954
+144.5% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 97.40361132241662.ToString("F0")% Shared 0.ToString("F0")% None 2.5963886775833767.ToString("F0")%

Common Shares in ALNY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

STIFEL FINANCIAL CORP holds $431,497,751 across 103 Biotechnology names. ALNY ranks #7 (3.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 ALNY
Alnylam Pharmaceuticals, Inc.
This page
49,954 $16,528,277

All Filings in ALNY

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $16,528,277 49,954
2025-12-31 $8,122,793 20,427
2025-09-30 $9,254,520 20,295
2025-06-30 $4,467,431 13,700
2025-03-31 $1,909,850 7,073
2024-12-31 $2,357,098 10,017
2024-09-30 $1,603,423 5,830
2024-06-30 $1,443,177 5,939
2024-03-31 $1,246,411 8,340
2023-12-31 $2,231,456 11,658
2023-09-30 $1,429,018 8,069
2023-06-30 $1,770,619 9,322
2023-03-31 $1,544,665 7,711
2022-12-31 $1,770,491 7,450
2022-09-30 $2,053,039 10,257
2022-06-30 $1,397,825 9,584
2022-03-31 $1,988,217 12,176
2021-12-31 $2,488,754 14,676
2021-09-30 $2,643,716 14,002
2021-06-30 $3,861,156 22,777
2021-03-31 $2,858,673 20,247
2020-12-31 $2,084,718 16,040
2020-09-30 $2,144,687 14,730
2020-06-30 $1,990,892 13,442
2020-03-31 $688,584 6,326